Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Understanding The Transmission Risks in Medication Administration


News Image

There are four primary points of contact where transmission can occur. Recognizing these vulnerabilities is the first step in mitigation, followed by proactive best practices.

Grane Rx recently released part one of a four-part series on Transmission Risks in Medication Administration. The document covers how to limit exposure to communicable diseases like COVID-19 by identifying where transmission may occur.

There are four primary points of contact where transmission can occur. Recognizing these vulnerabilities is the first step in mitigation, followed by proactive best practices. Here is a breakdown of the risk factors and Grane Rx solution set.

1. Packaging

Punch cards – also referred to as blister or bingo cards – are the highest risk packaging system. Nurses and caregivers have to handle them each and every time they administer medications to a resident or participant, typically multiple times a day. Medication pouch packs, on the other hand, require the least number of touches per day. Grane Rx SimplePack pouches are “touch and toss” that require the least number of touches.

2. Storage

Medication carts that hold the punch cards requires the highest amount of touch. Punch card filing forces nurses into a multi-touch process. The more a nurse has to handle medication packaging within the cart, the more opportunities to inadvertently introduce unwanted pathogens. SimplePacks on the other hand, are a multi-dose pouch packaging system that solve this problem by providing patient medications in pre-packaged rolls assembled via “no-touch” automation in the pharmacy. The packaged rolls are then stored in individual patient bins within the medication cart.

3. Administration

Physical distancing is one of the most effective ways to prevent disease transmission. While we can’t eliminate contact in senior care altogether, nor would we advise it due to the health benefits of human connections, we can limit contact for safety purposes. Reducing the frequency of medication administrations is an effective way to limit the spread of disease.

4. Medication Regimen

De-prescribing is the active process of optimizing a person’s medication list to remove medications that are no longer beneficial or could be causing harm. De-prescribing is part of good prescribing – backing off when doses are too high or stopping medications that are no longer needed.

About Grane Rx

Grane Rx is a high-touch senior care pharmacy and medication management provider. The organization’s end-to-end services include clinical consulting, staff training, on-going staff support, pharmacy transition facilitation, precision medication prescribing and state-of-the-art pharmacy automation. All solutions are designed to streamline senior care operations, optimize care and manage costs. Grane Rx works closely with our partners to build a collaborative relationship and ensure a smooth pharmacy transition.

About Grane Rx’s Meds2Home Program

Grane Rx has been leading PACE pharmacy solutions since 2006. We help PACE personnel streamline their operations, maximize their savings, and free-up staff time to focus on participant care. Through at home medication adherence systems, our Meds2Home program is revolutionizing senior care pharmacy by enabling participants to age safely and comfortably from home. Many of the PACE programs we serve are members of the National PACE Association.

Share article on social media or email:

Professional Disability Associates Introduces Behavioral Health Case Management Services


With the impact of COVID-19, we anticipate the volume and complexity of [behavioral health] claims to skyrocket. We are eager to bring more value to our customers by establishing long-term, meaningful strategies to address these claims.

Professional Disability Associates (PDA), a provider of specialty risk resources and consultative solutions to the disability insurance market, subsidiary of The Advocator Group and Brown & Brown, Inc. (NYSE: BRO), announced today the launch of a Behavioral Health Claim Management service. The offering serves to assist disability insurance carriers with improving the decision making, duration management, resource utilization, and return to work outcomes of these complex and, often, costly claims.

Utilizing innovative psychometric survey tools and the expertise of behavioral health clinicians, PDA will work with insurance carrier customers to identify behavioral health claims where psychosocial issues may be impacting functional capacity. Claims selected will follow a prescribed process, whereby the specific behavioral health issues are identified, assessed, and translated into how it impacts the claimant’s ability to work. Claims suited for this service include those with a primary behavioral health diagnosis, co-morbid behavioral health condition, undiagnosed behavioral health, or COVID-19 impacted claims.

PDA’s proprietary process for evaluating these claims includes an evaluation of medical history and a psychometric assessment of the claimant’s ability and mindset about returning to work, combined with an in-depth interview by a seasoned behavioral health clinician. Targeted strategies for future claim management can include a multi-disciplinary discussion, outreach to a treating provider, outreach to an employer, a peer review, an independent medical exam, and/or surveillance. Where possible, the service will also serve to make recommendations as to how to safely and securely return a claimant to work.

“We are at a critical inflection point in the management of disability claims,” notes Michael Shunney, Chief Executive Officer of PDA. “Behavioral health claims have always been among the most nebulous and demanding to manage for a disability claims operation. With the impact of COVID-19, we anticipate the volume and complexity of these claims to skyrocket. We are eager to bring more value to our customers by establishing long-term, meaningful strategies to address these claims.”

Dr. Joel Axler, MD, FAPA and National Behavioral Health Leader for Strategic Benefit Advisors, part of the Brown & Brown, Inc. team, remarks, “COVID-19 is accelerating the demand for behavioral health solutions and has already had substantial effects on health care, which will last far after the pandemic is over. There is a critical need for services that address issues all along the absence continuum – from employer-based solutions through to insights and actionable data at the long-term disability stage. I am delighted to see PDA bring forward an offering that meets a growing demand for these types of services.”

The Behavioral Health Claim Management offering can be integrated with any of PDA’s other consultative or specialized claims services for a comprehensive suite of services to address complex or resource-intensive disability claims.

To learn more about Professional Disability Associates, visit http://www.professionaldisabilityassociates.com.

ABOUT PROFESSIONAL DISABILITY ASSOCIATES

Professional Disability Associates (PDA) is an innovative industry leader in providing specialty risk resources, including medical and vocational review services, consultative solutions and industry benchmarking, as well as full-service claim administration capabilities to major disability insurers and self-insured employers. PDA prides itself on delivering customized solutions and exceeding its clients’ expectations. To learn more, please visit our website, http://www.professionaldisabilityassociates.com.

ABOUT THE ADVOCATOR GROUP

The Advocator Group, LLC is a nationwide advocacy organization dedicated to helping individuals apply for and obtain Social Security Disability Insurance. In addition, The Advocator Group assists Medicare beneficiaries in identifying the best coverage possible for their unique needs. The Advocator Group’s team of experienced Social Security and Medicare advocates ensures that each client is provided phenomenal service while each case receives close attention. For more information, visit advocator.com.

ABOUT BROWN & BROWN, INC.

Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm, providing risk management solutions to individuals and businesses. With more than 80 years of proven success and thousands of teammates, we offer knowledge you can trust and strive to deliver superior customer service. For more information, please visit bbinsurance.com.

Share article on social media or email:

Local Ann Arbor Doctor Opens Direct Primary Care Clinic


The beauty of Direct Primary Care is in its simplicity. There’s no health insurance, billing codes, corporations, waiting rooms, or middlemen to worry about – it’s just you and your doctor. It’s the most ‘Direct’ form of healthcare possible.

Ann Arbor Physician Dr. Jane Klaes announced the opening of her independent primary care practice on August 17th.

Following eight years as a Family Medicine Physician at Integrated Health Associates (IHA), Dr. Klaes opened her own clinic with the vision of providing personalized healthcare in the style of an old-fashioned small town doctor.

Set in the country just west of Ann Arbor, Dr. Klaes’ practice operates on a Direct Primary Care (DPC) model where patients pay flat monthly membership fees in return for comprehensive, individualized care. Health insurance is not required nor accepted.

“The beauty of Direct Primary Care is in its simplicity,” said Dr. Klaes. “There’s no health insurance, billing codes, corporations, waiting rooms, or middlemen to worry about – it’s just you and your doctor. It’s the most ‘Direct’ form of healthcare possible.”

Dr. Klaes says that DPC both extends health coverage to people without health insurance and also facilitates stronger doctor-patient relationships than conventional health systems are able to provide.

“My practice is a bit like a throwback to the old days,” she said. “Patients build a relationship with a doctor who knows and cares about them, and they work together towards greater wellness and quality of life. And since patients don’t pay extra for each visit, it’s easier to afford preventive care and get treatment before questions or health concerns pile up.”

Dr. Klaes offers direct access to her by phone, text, email or telemedicine and is available for urgent same-day or next-day appointments in virtually all cases.

She is excited to welcome new patients. Visit https://www.drjaneklaes.com/contact if you are interested in joining her practice.

About

Dr. Jane Klaes, DO practices family medicine in Ann Arbor utilizing an innovative approach to healthcare called Direct Primary Care. DPC is a membership-based model in which patients pay a low monthly fee in exchange for high quality, comprehensive care when and how they need it.

Share article on social media or email:

Germinator Awarded Vendor Contract by The Interlocal Purchasing System (TIPS)


Germinator provides a 100% safe and non-toxic sanitizing and disinfecting process, utilizing breakthrough technology scientifically proven to help reduce the threat of harmful bacteria and viruses.

We are thrilled to have been awarded a vendor contract within TIPS, said Jeff Gill, CEO of Germinator. This contract reduces the hassle and speeds up the process for organizations, allowing us to immediately begin sanitizing and disinfecting to help facilitate a safe and efficient reopening.

A national leader in a fast-growing industry, Germinator Mobile Sanitizing and Disinfecting is proud to announce that they were recently awarded a contract by The Interlocal Purchasing System (TIPS).

Based in Texas and consisting of over 11,000 Members, The Interlocal Purchasing System, more widely known as TIPS, is a successful and growing national purchasing cooperative. TIPS is a department of Region 8 Education Service Center, a governmental entity, located in Pittsburg, Texas. When permitted by law – instead of customers expending time, money, and resources on the extensive competitive bidding process – the use of TIPS permits public entities to quickly select and purchase work directly from Germinator since the company has already been competitively procured according to applicable state and federal bid laws.

“We are thrilled to have been awarded a vendor contract within TIPS,” said Jeff Gill, CEO of Germinator. “The current pandemic has created a difficult situation for school districts and organizations who are trying to figure out how to reopen safely and in a timely manner. This vendor contract reduces the hassle and speeds up the process for these organizations, allowing us to immediately begin thoroughly sanitizing and disinfecting to help facilitate a safe and efficient reopening.”

In addition to the TIPS contract, Germinator was recently awarded a vendor contract with TexBuy Purchasing Cooperative, which enables the company to perform work for the 62 school districts in Region 16 and additional districts and entities throughout the state of Texas.

Germinator provides a 100% safe and non-toxic sanitizing and disinfecting process, utilizing breakthrough technology scientifically proven to help reduce the threat of harmful bacteria and viruses similar to the novel coronavirus. Germinator is revolutionizing the industry, recently introducing the addition of ATP monitoring to its service offerings as part of a now patent-pending methodology. ATP monitoring allows Germinator to test surfaces for the potential presence of living microorganisms in as little as 10 seconds prior to sanitizing and disinfecting.

The company’s two-step process first sanitizes and disinfects surfaces and then provides surfaces with long-lasting protection against the growth of odor-causing bacteria, other types of bacteria which cause stains and discoloration, fungi such as mold and mildew, and algae.

The first step – Genesis – harnesses the power of hypochlorous acid (HOCl) to destroy bacteria, mold, mildew, viruses and odors caused by bacteria. HOCI is a non-toxic, near-neutral pH, hospital-grade sanitizer and disinfectant. The second step applies the Germinator’s Shield – an invisible microbial coating that protects surfaces for an extended period of time against the growth of mold, mildew and odor-causing bacteria. Both products are EPA registered and safe for humans, pets and the environment. The company’s highly trained field specialists employ best practices using electrostatic sprayers and wear Personal Protective Equipment (PPE) as appropriate.

Upholding the highest standards of sanitization and disinfecting, Germinator makes claims that are scientifically supported and within EPA regulations. Germinator’s research and process are validated by the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr – who was an Assistant to the United States Surgeon General for five administrations – and Dr. David Miller, the Protocol Chair of University of Rochester Center for AIDS Research Community Advisory Board.

Dr. Miller, supports Germinator’s process by saying, “The Germinator Genesis platform and the Shield microbial barrier application are at the forefront for facilities’ remediation of infectious diseases. This allows patients, providers, consumers, and commuters to have a high degree of confidence in the facility’s safety, which is an absolute necessity during the current COVID-19 pandemic.”

Germinator was founded in 2015 with the vision of providing a safe, effective and non-toxic method of proper sanitizing and disinfecting for businesses and households.

The company continues to expand across the country, providing communities with a proactive solution to help free environments from harmful germs, bacteria, and viruses. With Germinator, society can now have peace of mind and the freedom to live or work in a sanitized and disinfected environment. For more information, visit http://www.thegerminator.com.

Share article on social media or email:

Avalon Healthcare Solutions Ranks No. 4 on the 2020 Inc. 500 List of America’s Fastest-Growing Private Companies


Our growth over the past three years is a direct result of the dedication of our employees as we work to deliver on the triple aim in healthcare of improved cost, quality, and access through innovative laboratory benefit management technology.

Avalon Healthcare Solutions is pleased to announce it has achieved the No. 4 ranking on Inc.’s annual Inc. 500 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 500.

“The team at Avalon Healthcare Solutions is honored to rank so highly on this prestigious list of fast-growing private companies,” said Bill Kerr, MD, Avalon’s Chief Executive Officer, “Our growth over the past three years is a direct result of the dedication of our employees as we work to deliver on the triple aim in healthcare of improved cost, quality, and access through innovative laboratory benefit management technology.”

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 18.

About Avalon Healthcare Solutions

Avalon is a healthcare information technology and specialty benefit management company focused on laboratory testing. Avalon provides a comprehensive program to facilitate management of all outpatient laboratory services across all providers, including independent, physician office, and hospital-based laboratories. Using an independent Clinical Advisory Board, Avalon has developed a suite of science-based laboratory policies addressing all testing categories. The majority of these policies, reflecting high-volume, low-cost services, are administered through proprietary, automated technology, typically saving health plans 7 to 12 percent on outpatient laboratory spend. For more information about Avalon, please visit http://www.avalonhcs.com.

About Inc. 5000

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

Share article on social media or email:

Promaxo Announces Dr. Senthil Nathan and Dr. Clare Tempany as Medical Advisors


“Dr. Nathan and Dr. Tempany both bring extensive experience navigating unique challenges in prostate research,” said Dr. Amit Vohra, Co-Founder, and CEO of Promaxo. “Their perspectives will be invaluable as we scale and enhance our MRI guided product portfolio.”

Medical imaging, robotics, and AI technology company Promaxo, Inc. (Promaxo), announced Dr. Senthil Nathan and Dr. Clare Tempany as new key members of Promaxo’s advisory board. They bring specialized expertise in urology, radiology and prostate cancer research to navigate the future direction and further development of image-guided diagnosis and treatment capabilities.

“Dr. Nathan and Dr. Tempany both bring extensive experience navigating unique challenges in prostate research,” said Dr. Amit Vohra, Co-Founder, and CEO of Promaxo. “Their perspectives will be invaluable as we scale and enhance our MRI guided product portfolio.”

Dr. Nathan works at the University College Hospital and the Royal Free Hospital in London, as well as serves as a trustee among numerous educational organizations, including the SNJ Educational & Charitable Trust, the SNJ Education Fund, and the Prostate Cancer Research Foundation.

“Having witnessed the value of robotic techniques in urology and been part of the Imperial College team that carried out the world’s first true robotic surgery, I recognize the critical role MRI can play in streamlining prostate cancer treatment,” said Dr. Nathan. “I look forward to working with Promaxo to innovate this industry.”

Additionally, Promaxo welcomes Dr. Clare Tempany, who is the acting Medical Director and Chair of several international clinical trial committees, namely PI-RADS, ECOG-ACRIN in prostate MRI, and MRgFUS for uterine fibroid treatment. Having served as a faculty member at Johns Hopkins Medical Institution as well as the largest women’s hospital in the US, Dr. Tempany will provide invaluable insight toward Promaxo’s medical developments.

“I have been performing interventions under traditional MRI for almost a decade, pioneering the development of prostate cancer diagnosis, and image-guided therapy. I am incredibly impressed with the improvements the Promaxo team has accomplished with their in-office system,” said Dr. Tempany. “Promaxo is at the forefront of medical innovation and I’m excited to be part of it.”

Promaxo’s advisory team now includes 17 experts that cover everything from clinical development and industry forecasting to early market development and market launch. The deep skill sets and industry expertise of this combined team have aided in Promaxo’s rapid growth over the past 18-months.

About Promaxo, Inc.

Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 60 patents, the company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient screening and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups as it prepares to enter the US market.

To learn more about the technology behind the MRI system and its scope, visit: Promaxo.com.

LinkedIn: Promaxo

Twitter: @Promaxo

Facebook: Promaxo

Media Contact:

Lindsey Hill

Jive PR + Digital

e: lindseyhill@jiveprdigital.com

m: 951.566.6413

http://www.jiveprdigital.com

Share article on social media or email:

Advera Health Data Now Available via Bloomberg Enterprise Access Point


Advera Health Analytics, a market leader in cloud-based software and data-as-a-service drug safety solutions, today announced that its drug safety data is available to Bloomberg Data License clients via Bloomberg Enterprise Access Point. The data available will include drug safety risk signals that Advera curates from the FDA Adverse Event Reporting System (FAERS) data. FAERS is the U.S. national database containing information on drug adverse events and medication errors voluntarily reported to FDA about marketed drugs. Advera is a market leader in providing optimized and cleansed FAERS data, statistical analysis, and critical workflow tools to pharmaceutical companies, financial institutions, and large healthcare providers.

Advera’s FAERS database contains over 13 million adverse drug event reports, with 1.5 million events reported in 2019 alone. Every adverse drug event report is mapped to the appropriate pharmaceutical company, drug, condition, indication, and mechanism of action and also contains de-identified patient demographic data. Drug label information and statistical calculations of disproportionate reporting are also provided. Bloomberg Data License clients will be able to use Advera’s data for drug, company, and sector risk modeling.

“Post-marketing adverse event data can be used as a leading indicator for a variety of market triggers”, said Brian Overstreet, President and CEO of Advera Health. “The curated drug safety risk signals that we are providing to Bloomberg Data License subscribers can be used to detect emerging safety issues in approved drugs. The investment community is constantly looking for an edge and can now find it with quality data and advanced analytics. We’re excited to be working with Bloomberg and to be able to offer our drug safety data to their subscribers.”

About Advera Health Analytics

Advera Health Analytics is a global leader in pharmacovigilance software, analytics, and data at the leading edge of drug safety science. Advera Health has created Evidex, a next generation pharmacovigilance platform to connect disparate drug safety data sources and provide a user experience that elicits actionable intelligence from those data. The Evidex platform links to internal ICSR databases, FAERS, VigiBase, and other data and provides for a validated, audit ready environment to track and manage safety issues that are found in those data. Founded by a group of passionate healthcare entrepreneurs, Advera Health’s mission is to mitigate risk in the healthcare system by improving the transparency and actionability of drug safety data through the curation and aggregation of large disparate datasets and the application of advanced analytics and workflow. Please visit http://www.adverahealth.com.

Share article on social media or email:

As Medicare Open Enrollment Nears, Seniors Assess Proposed Program Changes


Medicare has some substantial changes in 2021.

More changes [in Medicare] will be announced after this November’s election; some of them possibly substantial.

As the October 15 Medicare open enrollment period approaches, the Centers for Medicare and Medicaid Services have announced a number of changes in Medicare procedures and coverage for calendar year 2021. “More changes will be announced after this November’s election,” says Ensurem CEO Dave Rich, “some of them possibly substantial. To help seniors plan ahead, we’ve been carefully following the major candidates’ healthcare platforms and proposals.”

As to the current changes, Rich, whose company is a growing online multicarrier insurance brokerage firm, notes that for the first time, all Medicare-eligible patients suffering from end-stage renal disease will be allowed to enroll in Medicare Advantage plans. Other changes include modification of data score targets to reflect disruption caused by the COVID-19 pandemic; a credit for Medicare Advantage providers serving certain rural areas; and expansion of the list of circumstances that could trigger a special enrollment period.(1)

Looking ahead, Rich notes that Democratic Party presidential candidate Joe Biden’s campaign announced a somewhat detailed healthcare plan in July. Key proposals in the plan call for the federal government to:

  • Lower Medicare age to 60. This would make roughly 20 million more people eligible for Medicare and would be funded by regular tax revenues.
  • Install a government-run public option. The option would be available to anyone, including the uninsured, beneficiaries in the ACA exchange, and people dissatisfied with their employer-sponsored coverage.
  • Boost the Affordable Care Act. The plan would reduce deductibles and co-pays for subsidized beneficiaries, as well as reduce the share of income subsidized households pay for coverage.
  • Stop surprise billing. Biden says he would bar providers from charging out-of-network rates in situations where the patient has no choice of provider, such as emergency surgery and ambulance transport.
  • Control prescription drug prices. Biden plans to repeal the exception that allows drug companies to avoid negotiating with Medicare over drug prices.(2)

President Donald Trump’s proposed 2021 budget, announced in February, contains about $500 million in net Medicare spending reductions over 10 years, most of which would come from reducing payments to healthcare providers.(3) In May, the Trump administration and the Centers for Medicare and Medicaid Services announced finalized requirements designed to:

  • Increase access to telehealth for services in Medicare Advantage plans;
  • Expand the range of supplemental benefits for beneficiaries with a Medicare Advantage plan who have chronic diseases;
  • Provide support for more Medicare Advantage options for patients living in rural areas; and
  • Expand access to Medicare Advantage for patients with end-stage renal disease.(4)

Regardless of the election’s results, says Rich, new Medicare enrollees in 2021 and beyond will face an increasingly broad array of choices. To help them evaluate those choices and make the best decision, Ensurem is developing artificial intelligence products that enable online product shopping and comparison.

These capabilities, Rich emphasizes, are designed to aid and supplement human expertise, not replace it. “Our technology,” he says, “is backed by a fully licensed and contracted contact center staffed with expert agents who can assist those requiring help beyond our online tools. By the end of the year, in fact, Ensurem will have nearly doubled its stable of in-house agents.”

About Ensurem:

Ensurem, headquartered in Clearwater, FL, is a leading technology and product distribution company serving carriers and consumers within the massive U.S. senior market. The company provides end-to-end solutions for carriers, including product development, digital marketing, and consumer-centric front ends and back end. For more information, please visit Ensurem.com

1.    “Fact Sheet 2021 Medicare Advantage and Part D Rate Announcement Fact Sheet.” CMS, cms.gov/newsroom/fact-sheets/2021-medicare-advantage-and-part-d-rate-announcement-fact-sheet.

2.    Pifer, Rebecca. “5 Key Pillars of Biden’s Healthcare Plan.” Healthcare Dive, 28 Apr. 2020, healthcaredive.com/news/5-key-pillars-of-bidens-healthcare-plan/576656/.

3.    “Medicare in the 2021 Trump Budget.” Center on Budget and Policy Priorities, 13 Feb. 2020, cbpp.org/blog/medicare-in-the-2021-trump-budget.

4.    “Trump Administration Announces Changes to Medicare Advantage and Part D to Provide Better Coverage and Increase Access for Medicare Beneficiaries.” CMS, cms.gov/newsroom/press-releases/trump-administration-announces-changes-medicare-advantage-and-part-d-provide-better-coverage-and.

Share article on social media or email:

Innopiphany Announces the Hiring of a New Head of Policy


Dr. Phil Ball

We are so fortunate to have Dr. Ball join our team. His knowledge and experience will be an invaluable asset to the company. He will add a depth of understanding to this new position and our clients will be the better for it

California-based life sciences consulting firm Innopiphany announced today the hiring of pharmaceutical executive Phil Ball, Ph.D., as the company’s new Principal, Head of Policy Practice.

Ball brings extensive international experience to the role. He has a proven track record of success in a range of roles, spanning from product development to global health policy. Most recently he was Executive Director, U.S. Value Policy and Strategy, at Allergan, where he led U.S. Health Economics and Outcomes Research- and value-related policy initiatives.

Ball’s responsibilities will include policy guidance and strategy to help pharmaceutical companies navigate potential legislative changes in drug pricing and patient access to treatments that are high on the list of priorities for lawmakers. The role will further help support policy innovation incentives to ensure that the industry has the resources to adequately respond to emergencies and meet rapid demand for vaccine and treatments like those we’ve seen in this pandemic.

“I am excited to join such a talented team and help advance Innopiphany’s policy capabilities. This is truly a pivotal moment in healthcare with a rapidly evolving policy landscape that is being further disrupted by the [COVID-19] pandemic,” Ball said. “I’m looking forward to ensuring our clients are fully aware of these critical developments and supporting them to execute a policy strategy that is aligned with their unique business priorities.”

“We are so fortunate to have Dr. Ball join our team. His knowledge and experience will be an invaluable asset to the company. He will add a depth of understanding to this new position and our clients will be the better for it,” said Managing Principal Dr. Lisa Kennedy.

About Innopiphany

Innopiphany is a Life Sciences consulting firm which specializes in Market Strategy, Forecasting, Market Access, Health Economics Outcomes Research (HEOR), and Healthcare Policy. All services are supported by advanced analytics, including data mining, data blending, natural language processing, predictive analytics, and data visualizations. The company has generated $150 million in new healthcare business in 30 countries for its clients. Innopiphany has achieved 100 percent repeat business from its clients through its rapid, on-time project delivery. It is headquarters is located in Los Angeles, CA. https://innopiphany.com/

Share article on social media or email:

MUSC Children’s Health Uses Proficient Health App to Connect Provider Community


Proficient Health Logp

A general practitioner concerned about whether a patient might need emergency care could use the app to connect with an on-call specialist for advice, even before the patient leaves the exam room.

Today Proficient Health announced that MUSC Children’s Health in Charleston, S.C., has selected PH Connect, a HIPAA-compliant software solution, for community-wide, provider-to-provider communications.

Part of the Medical University of South Carolina (MUSC) health system, MUSC Children’s Health specialists often field consultation requests from physicians across the Southeast. Calls were being answered by a central call center and transferred to the appropriate point of contact.

PH Connect eliminates the inefficiencies inherent in using a call center between providers without sacrificing the gatekeeper function that is necessary in large institutions characterized by changing shifts and schedules. Call routing is fully automated for quick, secure communication from any mobile device or PC.

Rather than dialing into a call center, providers use their PH Connect app to reach the right physician, practice or service line, without having to figure out who is on call or available. Integrated call schedules and intelligent routing always directs calls and messages to the appropriate provider, complete with any supporting notes, images and test results.

Dr. Mark Scheurer, Chief of MUSC Children’s and Women’s Health, is confident that PH Connect will make it much easier for clinicians statewide to reach his team, all while reducing call center volumes and operating costs.

“A general practitioner concerned about whether a patient might need emergency care could use the app to connect with an on-call specialist for advice, even before the patient leaves the exam room,” Scheurer says. “Those types of timely discussions can lead to faster treatment decisions and to better patient outcomes.”

For more information on PH Connect, visit https://proficienthealth.com/ph-connect. Or download our free white paper.

About MUSC Children’s Health

At MUSC Children’s Health, we are imagining what’s possible for each and every child by providing the pediatric expertise your child deserves and needs. From promoting healthy lifestyles to offering life-saving treatments, we deliver comprehensive and compassionate care to children throughout South Carolina and beyond. Our integrated health care system consists of MUSC Shawn Jenkins Children’s Hospital a 250-bed pediatric hospital providing the most advanced care possible in more than 26 specialty areas. We also provide the same depth and breadth of expertise in multiple neighborhood locations throughout the Lowcountry, offering primary, urgent and specialty care. As a Level 1 Trauma center, our pediatric emergency department specializes in providing emergency care for any serious injury or illness your child may experience at home, at school or at play. Working collaboratively with pediatricians throughout the community, MUSC Children’s Health also provides after-hours care to children from birth to 17 years of age in three different locations on weeknights, weekends and holidays. In addition to the clinical care MUSC Children’s Health provides, we are a major pediatric clinical research center conducting significant and ongoing research efforts through the Charles P. Darby Research Institute. This involvement allows us to enhance our ability to provide the highest level of care to children by translating laboratory advances to bedside, developing new technologies and providing clinical trials. For more information visit https://musckids.org.

About Proficient Health

Proficient Health is a healthcare information technology company specializing in solutions for the secure exchange of referrals and clinical information. Our affordable, online services and mobility solutions connect physicians, hospitals and other healthcare providers – helping them easily share and manage information, improve service and care delivery, drive down costs, speed reimbursement and get more out of their electronic medical records platform.

Share article on social media or email: